Zacks Investment Research on MSN

Amgen (AMGN) laps the stock market: Here's why

In the latest trading session, Amgen (AMGN) closed at $349.69, marking a +1.43% move from the previous day. This move outpaced the S&P 500's daily gain of 0.5%. On the other hand, the Dow registered a ...
Amgen Inc. (NASDAQ:AMGN) is included among the 15 Best S&P 500 Dividend Stocks to Buy in 2026. On January 20, Bernstein ...
If you want to know who really controls Amgen Inc. (NASDAQ:AMGN), then you'll have to look at the makeup of its share ...
Amgen Inc (AMGN) reached a significant milestone as its stock hit a 52-week high of $346.41. This marks a notable point for the biotechnology company, reflecting a positive trend over the past year.
As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the therapeutics industry, ...
If you buy and hold a stock for many years, you'd hope to be making a profit. But more than that, you probably want ...
Amgen says its MariTide obesity drug helped patients maintain weight loss for a second year, with good safety and fewer side ...
Amgen (NASDAQ: AMGN) has outperformed the market over the past 15 years by 1.17% on an annualized basis producing an average annual return of 13.01%. Currently, Amgen has a market capitalization of ...
Amgen Inc. Buy thesis: strong pipeline, 12% Q3 2025 revenue growth and MariTide obesity upside. Click for this updated look ...